Roivant Sciences United Kingdom — Net operating losses increased by 79.4% to $613.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 79.4%, from $342.00M to $613.40M.
roiv_segment_united_kingdom_net_operating_losses| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $40.10M | $63.80M | $162.60M | $342.00M | $613.40M |
| QoQ Change | — | +59.1% | +154.9% | +110.3% | +79.4% |
| YoY Change | — | +59.1% | +154.9% | +110.3% | +79.4% |